Table 2. The 3-year and 5-year OS rates for each LNR group.
| LNR stage | LNR group | No. of patients | 3-year OS | 5-year OS | HR | 95% CI |
|---|---|---|---|---|---|---|
| 0 | LNR = 0 | 364 | 89.3% | 80.6% | Ref. | |
| 1 | 0 < LNR ≤ 0.1 | 128 | 71.4% | 63.0% | 1.816 | 1.309–2.519 |
| 2 | 103 | |||||
| 0.1 < LNR ≤ 0.2 | 49 | 49.2% | 28.7% | 4.420 | 3.005–6.502 | |
| 0.2 < LNR ≤ 0.3 | 22 | 25.5% | 12.7% | 6.641 | 4.005–11.014 | |
| 0.3 < LNR ≤ 0.4 | 7 | 41.7% | 0% | 8.866 | 3.216–24.441 | |
| 0.4 < LNR ≤ 0.5 | 15 | 35.7% | 19.0% | 5.252 | 2.875–9.595 | |
| 0.5 < LNR ≤ 0.6 | 10 | 40.5% | 20.3% | 6.307 | 2.735–14.546 | |
| 3 | 10 | |||||
| 0.6 < LNR ≤ 0.7 | 4 | 0% | 0% | 18.465 | 6.673–51.097 | |
| 0.7 < LNR ≤ 0.8 | 2 | 0% | 0% | 21.250 | 5.112–88.335 | |
| 0.8 < LNR ≤ 0.9 | 1 | 0% | 0% | 17.324 | 2.379–126.155 | |
| 0.9 < LNR ≤ 1.0 | 3 | 0% | 0% | 33.186 | 10.194–108.037 |
LNR = lymph node ratio; OS = overall survival; HR = hazard ratio; CI = confidence interval.